A comprehensive view of AIDS / HIV-Positive. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

International AIDS Vaccine Initiative announces Phase 1 clinical trial to evaluate safety and immunogenicity of BG505 SOSIP.664 gp140 vaccine; study is being conducted with collaboration from AAHI and NIAID
Published: May 22, 2023 by Contify Life Science News
BMO upgrades Gilead Sciences to outperform and raises target to US$100, noting improving solid tumor oncology business, durable growth anchored by HIV/Virology business, best-in-class cell therapy franchise supported by strong manufacturing capabilities
Published: May 16, 2023 by Indian Investments Abroad
Doctors Without Borders/ Medecins Sans Frontires calls on Abbott and BD to ensure continued production of CD4 testing equipment to manage care for people with advanced HIV in low-resource settings; about 8 million CD4 tests are needed annually says MSF
Published: May 12, 2023 by States News Service
HHS awards US$147M to 49 recipients to support ending the HIV epidemic in the US; White House sets goal to reduce number of new HIV infections in US by 90% by 2030
Published: April 27, 2023 by U.S. Dept. of Health and Human Services (HHS)
Merck reports HIV combo trial is back in the running after FDA partial hold lifted; combo therapy of oral islatravir and Gilead’s Sunlenca to start Phase 2 study after closing the trial in November 2021
Published: April 27, 2023 by FierceBiotech

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count